Title
The association between psychotic experiences and disability: results from the WHO World Mental Health Surveys
Date Issued
01 July 2017
Access level
open access
Resource Type
journal article
Author(s)
Navarro-Mateu F.
Alonso J.
Lim C.C.W.
Saha S.
Aguilar-Gaxiola S.
Al-Hamzawi A.
Andrade L.H.
Bromet E.J.
Bruffaerts R.
Chatterji S.
Degenhardt L.
de Girolamo G.
de Jonge P.
Fayyad J.
Florescu S.
Gureje O.
Haro J.M.
Hu C.
Karam E.G.
Kovess-Masfety V.
Lee S.
Medina-Mora M.E.
Ojagbemi A.
Pennell B.E.
Posada-Villa J.
Scott K.M.
Stagnaro J.C.
Xavier M.
Kendler K.S.
Kessler R.C.
McGrath J.J.
Al-Kaisy M.S.
Benjet C.
Borges G.
Bunting B.
de Almeida J.M.C.
Cardoso G.
Cia A.H.
Demyttenaere K.
He Y.
Hinkov H.
Huang Y.
Karam A.N.
Kawakami N.
Kiejna A.
Lepine J.P.
Levinson D.
Moskalewicz J.
Slade T.
Stein D.J.
Have M.t.
Torres Y.
Viana M.C.
Whiteford H.
Williams D.R.
Wojtyniak B.
Publisher(s)
Blackwell Publishing Ltd
John Wiley & Sons, Inc
Abstract
Objective: While psychotic experiences (PEs) are known to be associated with a range of mental and general medical disorders, little is known about the association between PEs and measures of disability. We aimed to investigate this question using the World Mental Health surveys. Method: Lifetime occurrences of six types of PEs were assessed along with 21 mental disorders and 14 general medical conditions. Disability was assessed with a modified version of the WHO Disability Assessment Schedule. Descriptive statistics and logistic regression models were used to investigate the association between PEs and high disability scores (top quartile) with various adjustments. Results: Respondents with PEs were more likely to have top quartile scores on global disability than respondents without PEs (19.1% vs. 7.5%; χ2 = 190.1, P < 0.001) as well as greater likelihood of cognitive, social, and role impairment. Relationships persisted in each adjusted model. A significant dose–response relationship was also found for the PE type measures with most of these outcomes. Conclusions: Psychotic experiences are associated with disability measures with a dose–response relationship. These results are consistent with the view that PEs are associated with disability regardless of the presence of comorbid mental or general medical disorders.
Start page
74
End page
84
Volume
136
Issue
1
Language
English
OCDE Knowledge area
Psiquiatría
Psicología (incluye relaciones hombre-máquina)
Subjects
Scopus EID
2-s2.0-85019931404
PubMed ID
Source
Acta Psychiatrica Scandinavica
ISSN of the container
0001690X
Sponsor(s)
The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this study. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the World Health Organization, other sponsoring organizations, agencies, or governments. The Argentina survey?Estudio Argentino de Epidemiolog?a en Salud Mental (EASM)?was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Naci?n). The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042, SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy)), Fondo de Investigaci?n Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnolog?a, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi MOH and MOP with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF). The Lebanese Evaluation of the Burden of Ailments and Needs Of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health/Fogarty International Center (R03 TW006481-01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, Servier, Phenicia, UPO. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). Te Rau Hinengaro: The New Zealand Mental Health Survey (NZMHS) is supported by the New Zealand Ministry of Health, Alcohol Advisory Council, and the Health Research Council. The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health. The Romania WMH study projects ?Policies in Mental Health Area? and ?National Study regarding Mental Health and Services Use? were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health, present National School of Public Health Management & Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics?National Centre for Training in Statistics, SC. Cheyenne Services SRL, Statistics Netherlands, and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The S?o Paulo Megacity Mental Health Survey is supported by the State of S?o Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204-3. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. John McGrath received John Cade Fellowship APP1056929 from the National Health and Medical Research Council and Niels Bohr Professorship from the Danish National Research Foundation. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/.
Sources of information:
Directorio de Producción Científica
Scopus